<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>Laboratorul de otorinolaringologie</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/33423</link>
<description/>
<pubDate>Wed, 08 Jul 2026 09:54:59 GMT</pubDate>
<dc:date>2026-07-08T09:54:59Z</dc:date>
<item>
<title>Postoperative autologous peripheral blood mononuclear cell therapy in the rehabilitation of children with chronic hypertrophic rhinitis: a prospective comparative study</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/33424</link>
<description>Postoperative autologous peripheral blood mononuclear cell therapy in the rehabilitation of children with chronic hypertrophic rhinitis: a prospective comparative study
Furculița, Daniel; Maniuc, Mihail; Danilov, Lucian; Ababii, Polina
Chronic hypertrophic rhinitis in children is a common pathology associated with inferior&#13;
turbinate hypertrophy, persistent nasal obstruction, and impaired quality of life. Surgical&#13;
interventions to reduce turbinate volume, such as diode laser and bipolar cautery, are widely&#13;
used, but postoperative inflammation and mucosal regeneration can be prolonged. Autologous&#13;
cell therapy represents a promising regenerative approach to accelerate tissue healing.&#13;
Objective – to evaluate the effectiveness of postoperative autologous mononuclear cell&#13;
therapy in the rehabilitation of children with chronic hypertrophic rhinitis following surgical&#13;
treatment.&#13;
Methods. The study was prospective, interventional, and comparative, conducted on a&#13;
group of 40 children aged 7 to 17 years diagnosed with chronic hypertrophic rhinitis. Patients&#13;
were divided into four groups (n = 10/group): diode laser (DL), diode laser + cell therapy&#13;
(DL+CT), bipolar cautery (BC), and bipolar cautery + cell therapy (BC+CT). Cell therapy&#13;
consisted of the postoperative local administration of a suspension of autologous mononuclear&#13;
cells obtained from peripheral blood. The evaluation included the NOSE symptom score,&#13;
rhinomanometry, acoustic rhinometry and endoscopic examination. The follow-up period was 24&#13;
months.&#13;
Results. All groups showed postoperative clinical improvement. The cell therapy groups&#13;
demonstrated a significantly faster and more stable reduction in symptoms, with a decrease in&#13;
the NOSE score to 14.0 ± 4.0 in the DL+CT group at 24 months, compared to 30.0 ± 6.0 in DL and&#13;
36.0 ± 7.0 in BC. Nasal resistance decreased more sharply in the cell therapy groups, and the&#13;
incidence of persistent edema, crusting and relapses was lower.&#13;
Conclusions. Autologous cell therapy applied postoperatively accelerates the regeneration&#13;
of the nasal mucosa and improves functional outcomes in children with chronic hypertrophic&#13;
rhinitis, with maximum efficiency in combination with diode laser.
</description>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/33424</guid>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
